Perimeter Medical Imaging AI Announces Initiation of Additional Clinical Trial Site at Baptist MD Anderson Cancer Center in Jacksonville, FL

Perimeter Medical Imaging AI,a commercial-stage medical technology company announced the initiation of an additional clinical trial site at Baptist MD Anderson Cancer Center in Jacksonville, FL under the direction of Laila Samiian, MD, FACS.

Latest Insights: NVIDIA Introduces NeMo Guardrails to Enable Safety & Security for LLMs

Laila Samiian, MD, FACS, Director, Breast Program at Baptist MD Anderson Cancer Center, stated, “We are excited to become the newest active site with three investigators anticipated to participate in this clinical study to assess if the Perimeter B-Series with artificial intelligence demonstrates an improvement over the current standard of care. Combining optical coherence tomography with deep learning algorithms could assist us, as surgeons, to better identify regions of interest supporting ‘real-time’ decisions on margin status in the OR – potentially setting a new standard for specimen imaging technology during breast conservation surgery.”

Recommended: AiThority Interview with Mary-Lou Smulders, Chief Marketing Officer at Dedrone

Jeremy Sobotta, Perimeter’s Chief Executive Officer stated, “Our ongoing pivotal clinical trial evaluating our breakthrough-device-designated Perimeter B-Series OCT technology with proprietary, next-gen ‘ImgAssist’ artificial intelligence continues to advance. All initially planned sites have been activated, and we recently received FDA approval to expand the number of institutions to further support patient enrollment. We are excited to initiate Baptist MD Anderson Cancer Center with the goal of further accelerating study completion.”

Latest Insights: Data Annotation as the Key to Military Mastery and National Security

[To share your insights with us, please write to sghosh@martechseries.com]